Morgan Stanley raised its price objective for Iridium, while Raymond James Financial restated its market perform rating, with MarketBeat providing consensus data.
1 report, 1 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley raised its price objective for Iridium, while Raymond James Financial restated its market perform rating, with MarketBeat providing consensus data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
iridium
chemical element with symbol Ir and atomic number 77
-
Morgan Stanley
U.S. investment bank
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- MarketBeat provided average rating data for Quince Therapeutics, Inc., following a stock rating boost from Raymond James Financial.
- Analyst firms, including Keefe, Bruyette & Woods and Morgan Stanley, boosted price targets for Miami International Holdings, Inc.
- Analyst firms, including Benchmark, Morgan Stanley, and Cantor Fitzgerald, issued rating and price target updates for Spotify Technology.
- Multiple financial firms, including Jefferies, Bank of America, and Raymond James, issued price objective and rating updates on October 23, 2026.
- MarketBeat reported MetLife's average rating while Morgan Stanley raised its price target and Bank of America cut its price objective.